In an 86‑year‑old male with ferritin 585 ng/mL, serum iron 45 µg/dL, total iron‑binding capacity (TIBC) 274 µg/dL, transferrin saturation 16 %, hemoglobin 13.3 g/dL, and alkaline phosphatase 165 U/L, what is the most likely diagnosis and appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Anemia of Chronic Disease (Inflammation) with Possible Concurrent Iron Deficiency

This patient has anemia of chronic disease (ACD) as evidenced by elevated ferritin (585 ng/mL) with low transferrin saturation (16%), and the elevated alkaline phosphatase suggests an underlying inflammatory or chronic condition driving this picture.

Diagnostic Interpretation

The laboratory pattern is classic for ACD:

  • Ferritin 585 ng/mL: Markedly elevated, indicating either inflammation or adequate/excess iron stores 1
  • Transferrin saturation 16%: Low, suggesting functional iron deficiency (iron trapped in stores, unavailable for erythropoiesis)
  • TIBC 274 µg/dL: Low-normal (inflammation suppresses TIBC) 2
  • Hemoglobin 13.3 g/dL: Mild anemia for an elderly male
  • Alkaline phosphatase 165 U/L: Elevated, pointing to underlying chronic disease (liver disease, bone disease, malignancy, or chronic inflammation)

The key distinction: In true iron deficiency anemia, ferritin would be <45 ng/mL 3, and TIBC would typically be elevated (>350 µg/dL) 2. This patient's elevated ferritin with low TIBC indicates inflammation is driving the anemia, not simple iron deficiency.

Critical Caveat: Mixed Picture Possibility

While ACD is the primary diagnosis, functional iron deficiency can coexist with ACD when ferritin is between 100-800 ng/mL with transferrin saturation <20% 4, 5. This patient falls into this gray zone. The low transferrin saturation (16%) suggests iron is sequestered and unavailable for red blood cell production despite adequate stores.

Recommended Diagnostic Workup

Immediate next steps to confirm and characterize:

  1. C-reactive protein (CRP): Essential to confirm inflammation 6, 5. If CRP ≥5 mg/L, this confirms the inflammatory component affecting iron metabolism.

  2. Soluble transferrin receptor (sTfR) or reticulocyte hemoglobin content (CHr): These markers are not affected by inflammation and can identify true iron deficiency even when ferritin is elevated 4, 6. If sTfR is elevated or CHr is low, concurrent true iron deficiency exists.

  3. Investigate the elevated alkaline phosphatase:

    • Fractionate alkaline phosphatase (liver vs. bone isoenzymes)
    • Liver function tests (AST, ALT, bilirubin, albumin)
    • Consider imaging (ultrasound or CT) if hepatobiliary source suspected
    • Evaluate for occult malignancy, chronic infection, or inflammatory conditions

  4. Bidirectional endoscopy: Despite the elevated ferritin, if sTfR or CHr confirms iron deficiency, proceed with esophagogastroduodenoscopy and colonoscopy to evaluate for gastrointestinal blood loss 3. An 86-year-old male warrants GI evaluation even with atypical iron studies if any component of true iron deficiency is present.

Management Algorithm

Step 1: Obtain CRP, sTfR (or CHr), and investigate alkaline phosphatase elevation.

Step 2:

  • If sTfR elevated/CHr low (true iron deficiency present): Treat underlying inflammation AND replace iron. Consider intravenous iron rather than oral, as inflammation impairs oral iron absorption via hepcidin upregulation 1, 4. Proceed with bidirectional endoscopy 3.

  • If sTfR normal/CHr normal (pure ACD): Focus on treating the underlying chronic disease causing inflammation. Iron supplementation is not indicated and may be harmful.

Step 3: Address the underlying chronic disease identified by alkaline phosphatase workup and clinical evaluation.

Common Pitfalls

  • Do not empirically supplement iron based on low transferrin saturation alone when ferritin is elevated. This can worsen outcomes in pure ACD by promoting oxidative stress and bacterial growth.

  • Do not dismiss gastrointestinal pathology in elderly patients even with elevated ferritin. Occult GI bleeding can coexist with inflammatory conditions 3.

  • Recognize that standard ferritin thresholds (<45 ng/mL) do not apply in inflammatory states 1, 4. Additional testing is mandatory.

  • In this age group, malignancy, chronic infection, and inflammatory conditions (polymyalgia rheumatica, temporal arteritis, occult abscess) are common causes of elevated alkaline phosphatase and ACD.

312465

References

4
Research

Assessing iron status: beyond serum ferritin and transferrin saturation.

Clinical journal of the American Society of Nephrology : CJASN, 2006

Related Questions

With ferritin 200 µg/L, transferrin saturation 13 % and a normal complete blood count, what does this indicate and what should be the next diagnostic steps?
With a ferritin of 26 ng/mL, low‑normal serum iron, high total iron‑binding capacity, low transferrin saturation, and elevated unsaturated iron‑binding capacity, what is the diagnosis and recommended next steps for evaluation and treatment?
In a 28-year-old male with ferritin 482 µg/L, serum iron 82 µg/dL, unsaturated iron‑binding capacity (UIBC) 189 µg/dL, total iron‑binding capacity (TIBC) 271 µg/dL, and iron saturation 30%, what is the most likely explanation and recommended next steps?
What type of anemia does a 74‑year‑old polymorbid woman with hemoglobin 122 g/L, hematocrit 0.37, MCV 91.4 fL, MCH 30.1 pg, RDW 15 %, serum iron 13.4 µmol/L, transferrin 3.08 g/L, transferrin saturation 17.3 %, ferritin 39.9 µg/L, and CRP 4.41 mg/L have?
Given a ferritin of 228 µg/L, normal C‑reactive protein, normal erythrocyte sedimentation rate, low transferrin saturation and high‑normal total iron‑binding capacity with normal hemoglobin and hematocrit, what is the likely cause and recommended management?
Can vortioxetine cause tremor?
How should Januvia (sitagliptin) and Jardiance (empagliflozin) be used together, including appropriate dosing, renal function requirements, and monitoring recommendations?
How should I manage depression in a patient who has undergone mastectomy?
Does lithium cause urinary incontinence?
What is the clinical significance of a mild elevation of kappa light chains?
What is the history and interesting facts about cataracts?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.